73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

by Katie Neith,City of Hope National Medical CenterCredit: Unsplash/CC0 Public DomainIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology,

Researchers pinpoint nongenetic mechanisms in lung cancer resistance to one commonly used therapy

by Katie Neith,City of Hope National Medical CenterCredit: Unsplash/CC0 Public DomainIn a recent study led by Ravi Salgia, M.D., Ph.D., the Arthur & Rosalie Kaplan Chair in Medical Oncology,
New anti-cancer 'degrader' targets protein essential to infant leukemia

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti

New anti-cancer 'degrader' targets protein essential to infant leukemia

byVan Andel Research InstituteDiscovery of a first-in-class, highly potent VHL-recruiting ENL PROTAC degrader, MS41. Credit:Science Advances(2024). DOI: 10.1126/sciadv.ado1432Scienti
Researchers identify possible approach to prevent cancer from evolving to resist treatment

Researchers identify possible approach to prevent cancer from evolving to resist treatment

by University of California, Los AngelesSingle-agent inhibitory potencies in human melanoma, PDAC, and NSCLC clonogenic growth assays. A to G, Long-term clonogenic growth of indicated BRAFV600MUT

Researchers identify possible approach to prevent cancer from evolving to resist treatment

by University of California, Los AngelesSingle-agent inhibitory potencies in human melanoma, PDAC, and NSCLC clonogenic growth assays. A to G, Long-term clonogenic growth of indicated BRAFV600MUT
Crossroads: The role of biomarkers in the management of lumps in the breast

Crossroads: The role of biomarkers in the management of lumps in the breast

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new research perspective was published inOncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in

Crossroads: The role of biomarkers in the management of lumps in the breast

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainA new research perspective was published inOncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in
Automated bone scan index prognostic for prostate cancer

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud

Automated bone scan index prognostic for prostate cancer

(HealthDay)—The automated Bone Scan Index (aBSI) is an independent prognostic imaging biomarker of overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC), according to a stud
Using AI during cancer-screening results in more recommended controls

Using AI during cancer-screening results in more recommended controls

by Mathilde Coraline Aarvold Bakke,University of OsloGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.08.022A polyp is a small growt

Using AI during cancer-screening results in more recommended controls

by Mathilde Coraline Aarvold Bakke,University of OsloGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.08.022A polyp is a small growt
Newly developed inhibitor shows potential for prostate cancer

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs

Newly developed inhibitor shows potential for prostate cancer

JANUARY 9, 2024byAlbert Ludwigs University of FreiburgIdentification of a bi-substrate inhibitor of KMT9.aChemical structure of compound1awith predicted binding mode.&nbs
New method to detect cancer cells faster, potentially improving outcomes

New method to detect cancer cells faster, potentially improving outcomes

by Purdue UniversityA Purdue University team developed a method to screen one-bead-one-compound libraries against biological targets such as proteins or antibodies. Credit: Purdue UniversityThe d

New method to detect cancer cells faster, potentially improving outcomes

by Purdue UniversityA Purdue University team developed a method to screen one-bead-one-compound libraries against biological targets such as proteins or antibodies. Credit: Purdue UniversityThe d
3-D-printed tumor model shows interaction with immune cells

3-D-printed tumor model shows interaction with immune cells

by Wiebe Van Der Veen,University of TwenteThe size of the model, the red part is thetumor. Credit: University of TwenteAround a glioblastoma, a very aggressive brain tumor, cells of the hu

3-D-printed tumor model shows interaction with immune cells

by Wiebe Van Der Veen,University of TwenteThe size of the model, the red part is thetumor. Credit: University of TwenteAround a glioblastoma, a very aggressive brain tumor, cells of the hu
Pancreatic cancer tumor classification could optimize treatment choices

Pancreatic cancer tumor classification could optimize treatment choices

by UNC Lineberger Comprehensive Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study from the University of North Caroli

Pancreatic cancer tumor classification could optimize treatment choices

by UNC Lineberger Comprehensive Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study from the University of North Caroli
A new approach to targeting cancer cells

A new approach to targeting cancer cells

by University of California - RiversideThe Pellecchia lab at UC Riverside is working on an approach in which effective drugs can be obtained by appropriately designing molecules to contain an ary

A new approach to targeting cancer cells

by University of California - RiversideThe Pellecchia lab at UC Riverside is working on an approach in which effective drugs can be obtained by appropriately designing molecules to contain an ary
Study explores current pharmacy practice in cardio-oncology

Study explores current pharmacy practice in cardio-oncology

by Milana Madzarac,University of WaterlooCredit: Unsplash/CC0 Public DomainA structured support system for oncology patients is one of the most important aspects during a difficult time in someo

Study explores current pharmacy practice in cardio-oncology

by Milana Madzarac,University of WaterlooCredit: Unsplash/CC0 Public DomainA structured support system for oncology patients is one of the most important aspects during a difficult time in someo